Viagra like drug for women

Author: Symon On: 13-Feb-2018
Is There <i>Viagra</i> For <i>Women</i>? POPSUGAR News

Is There Viagra For Women? POPSUGAR News

The United States Food and Drug Administration has recently approved a controversial pink pill containing the drug flibanserin, that’s being marketed to women as treatment to improve sexual function. Branded as Addyi by Sprout Pharmaceuticals, who currently own the patent, the drug has been approved in United States to treat a condition known as female hypoactive sexual desire disorder (HSDD). Occurring in up to one-third of adult women in the U. S., according to a paper published in the National Library of Medicine, researchers define the disorder as: “a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty.” An FDA advisory panel voted against approving flibanserin in 2010, when it was first presented by the German pharmaceutical company Boehringer Ingelheim, who originally developed it. After the panel rejected it — on the grounds that the drug’s impact was “not robust enough to justify the risks” — Boehringer Ingelheim passed the patent rights for flibanserin on to Sprout Pharmaceuticals. Known side effects of flibanserin include dizziness, nausea, fatigue, sudden loss of consciousness, lower blood pressure, sleepiness and harmful interactions with alcohol. Sprout Pharmaceuticals subsequently attempted — and failed again — to gain FDA approval in June 2013. WASHINGTON/NEW YORK (Reuters) - The first drug to treat low sexual desire in women won approval from U. health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol. Addyi, whose chemical name is flibanserin, is designed for premenopausal women whose lack of sexual desire causes distress. Food and Drug Administration said the pink pill, to be sold under the brand name Addyi and made by privately held Sprout Pharmaceuticals, will only be available through certified and specially trained health care professionals and pharmacies due to its safety issues. The condition is formally known as hypoactive sexual desire disorder, or HSDD. Addyi has been nicknamed the “female Viagra” even though it does not work like Pfizer Inc’s blockbuster Viagra pill for men that in 1998 became the first approved drug for erectile dysfunction. “This is the biggest breakthrough in women’s sexual health since the advent of ‘the Pill’” for contraception, The National Consumers League said in a statement. “It validates (and) legitimizes female sexuality as an important component of health.” But Public Citizen, a consumer watchdog group that testified against the drug earlier this year, predicted that Addyi will be pulled from the market within a few years because of “serious dangers to women, with little benefit” to them. “Unfortunately, we haven’t heard the last of this drug.” The FDA had twice rejected the Raleigh, North Carolina-based firm’s drug. But the latest decision comes after an advisory panel concluded in June it should be approved with strict measures in place to ensure patients are fully aware of the risks.

Female <b>viagra</b>' rocks Finally, <b>women</b> get their own little blue pill
Female viagra' rocks Finally, women get their own little blue pill

Jun 9, 2015. An advisory committee to the Food and Drug Administration FDA voted 18-6 last week to recommend flibanserin for approval. But this 'pink pill' is not at all like the famous 'blue pill' Viagra, which works by increasing blood flow to the sex organs. Flibanserin, which will be marketed under the name Addyi. A new study has found that the impotence drug Viagra could ramp up the sex lives of women who take it, just as it has done for men. The 12-week study focused on 202 post-menopausal or post-hysterectomy women who complained of female sexual arousal disorder. The women in the group who took Sildenafil — the little.

Viagra like drug for women
Rating 4,5 stars - 282 reviews